News for Cipher Pharmaceuticals Inc. (CPHRF)

Total Net Revenue (Q3 2024): $10.4 million, a 71% increase compared to the same quarter in the prior year.Total Net Revenue (9 months ended September 30, 2024)

Nov 08, 2024 / 01:30PM GMTOperator Good morning, ladies and gentlemen. And thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $14.60 million, and th

May 10, 2024 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ETCompany ParticipantsCraig J.

MANAGEMENT'S DISCUSSION AND ANALYSIS For the three months ended March 31, 2024 MANAGEMENT'S DISCUSSION AND ANALYSIS ...

Cipher Pharmaceuticals will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. ...

Mar 15, 2024 / 12:30PM GMTOperator Good morning, ladies and gentlemen, thank you for standing by, and welcome to the Cipher Pharmaceuticals Fourth Quarter and F

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q4 2023 Earnings Conference Call March 15, 2024 8:30 AM ETCompany ParticipantsCraig Mull - Chief Executive Officer...

The 3D printed wearables market is bolstered by the rising cases of neuroblastoma among adolescents drive the demand for isotretinoin drugs. The prevalence...

The increasing prevalence of autoimmune disorders, including conditions like Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease, is a key driver...

The emergence of new products in the pipeline will add to the musculoskeletal pain market growth in the future. In addition, persistently rising cases of...

Sjogren's syndrome market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness...

The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for...

/PRNewswire/ -- The acne drugs market size is forecast to increase by USD 907.11 million from 2022 to 2027, at a CAGR of 3.46%, according to the recent market...

/PRNewswire/ -- The "Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...

/PRNewswire/ -- DelveInsight's 'Rheumatoid Arthritis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

/PRNewswire/ -- The "Global Acne Drugs Market (2021-2026) by Acne Type, Therapeutic Class, Drug Type, Drug Formulation, Distribution Channel, and Geography,...

SAN DIEGO, June 10, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. , a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical needs for new... | June 10, 2021